Michael Stocks

Prof. Michael Stocks

orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FSFadi Soukarieh
Fadi Soukarieh
PWPaul Williams
Paul Williams
MSMichael Stocks
Michael Stocks
MCMiguel Cámara
Miguel Cámara

24 December 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AGAimie E. Garces
Aimie E. Garces
MSMichael Stocks
Michael Stocks

3 February 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SGSimon D. Guile
Simon D. Guile
LALilian Alcaraz
Lilian Alcaraz
TBTimothy N. Birkinshaw
Timothy N. Birkinshaw
KBKeith C. Bowers
Keith C. Bowers
MEMark R. Ebden
Mark R. Ebden
MSMichael Stocks
Michael Stocks

26 August 2010 in Organic Letters
Verified
Journal Article
Closed access
BRBryan Roberts
Bryan Roberts
DLDavid Liptrot
David Liptrot
LALilian Alcaraz
Lilian Alcaraz
TLTim Luker
Tim Luker
MSMichael Stocks
Michael Stocks

22 July 2004 in Organic Letters
Verified
Journal Article
Closed access
MSMichael Stocks
Michael Stocks
DCDavid R. Cheshire
David R. Cheshire
RRRachel Reynolds
Rachel Reynolds

1 December 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Open access
SGScott Grossman
Scott Grossman
FSFadi Soukarieh
Fadi Soukarieh
WRWilliam Richardson
William Richardson
RLRuiling Liu
Ruiling Liu
AMAlaa Mashabi
Alaa Mashabi
MSMichael Stocks
Michael Stocks
Rising numbers of cases of multidrug- and extensively drug-resistant Pseudomonas aeruginosa over recent years have created an urgent need for novel therapeutic approaches to cure potentially fatal infections. One such approach is virulence attenuation where anti-virulence compounds, designed to reduce pathogenicity without affording bactericidal effects, are employed to treat infections. P. aeruginosa uses the pqs quorum sensing (QS) system, to coordinate the expression of a large number of virulence determinants as well as bacterial-host interactions and hence represents an excellent anti-virulence target.